Cargando…
Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data
PURPOSE: To evaluate the prevalence and treatment patterns of speech and language disorders in Germany. METHODS: A retrospective analysis of data collected from 32% of the German population, insured by the statutory German health insurance (AOK, Local Health Care Funds). We used The International St...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071871/ https://www.ncbi.nlm.nih.gov/pubmed/33912020 http://dx.doi.org/10.3389/fnhum.2021.645292 |
_version_ | 1783683799694966784 |
---|---|
author | Sommer, Martin Waltersbacher, Andrea Schlotmann, Andreas Schröder, Helmut Strzelczyk, Adam |
author_facet | Sommer, Martin Waltersbacher, Andrea Schlotmann, Andreas Schröder, Helmut Strzelczyk, Adam |
author_sort | Sommer, Martin |
collection | PubMed |
description | PURPOSE: To evaluate the prevalence and treatment patterns of speech and language disorders in Germany. METHODS: A retrospective analysis of data collected from 32% of the German population, insured by the statutory German health insurance (AOK, Local Health Care Funds). We used The International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification (ICD-10 GM) codes for stuttering (F98.5), cluttering (F98.6), and developmental disorders of speech and language (F80) to identify prevalent and newly diagnosed cases each year. Prescription and speech therapy reimbursement data were used to evaluate treatment patterns. RESULTS: In 2017, 27,977 patients of all ages were diagnosed with stuttering (21,045 males, 75% and 6,932 females, 25%). Stuttering prevalence peaks at age 5 years (boys, 0.89% and girls, 0.40%). Cluttering was diagnosed in 1,800 patients of all ages (1,287 males, 71.5% and 513 females, 28.5%). Developmental disorders of speech and language were identified in 555,774 AOK-insurants (61.2% males and 38.8% females). Treatment data indicate a substantial proportion newly diagnosed stuttering individuals receive treatment (up to 45% of 6-year-old patients), with slightly fewer than 20 sessions per year, on average. We confirmed a previous study showing increased rates of atopic disorders and neurological and psychiatric comorbidities in individuals with stuttering, cluttering, and developmental disorders of speech and language. CONCLUSION: This is the first nationwide study using health insurance data to analyze the prevalence and newly diagnosed cases of a speech and language disorder. Prevalence and gender ratio data were consistent with the international literature. The crude prevalence of developmental disorders of speech and language increased from 2015 to 2018, whereas the crude prevalence for stuttering remained stable. For cluttering, the numbers were too low to draw reliable conclusions. Proportional treatment allocation for stuttering peaked at 6 years of age, which is the school entrance year, and is later than the prevalence peak of stuttering. |
format | Online Article Text |
id | pubmed-8071871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80718712021-04-27 Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data Sommer, Martin Waltersbacher, Andrea Schlotmann, Andreas Schröder, Helmut Strzelczyk, Adam Front Hum Neurosci Neuroscience PURPOSE: To evaluate the prevalence and treatment patterns of speech and language disorders in Germany. METHODS: A retrospective analysis of data collected from 32% of the German population, insured by the statutory German health insurance (AOK, Local Health Care Funds). We used The International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification (ICD-10 GM) codes for stuttering (F98.5), cluttering (F98.6), and developmental disorders of speech and language (F80) to identify prevalent and newly diagnosed cases each year. Prescription and speech therapy reimbursement data were used to evaluate treatment patterns. RESULTS: In 2017, 27,977 patients of all ages were diagnosed with stuttering (21,045 males, 75% and 6,932 females, 25%). Stuttering prevalence peaks at age 5 years (boys, 0.89% and girls, 0.40%). Cluttering was diagnosed in 1,800 patients of all ages (1,287 males, 71.5% and 513 females, 28.5%). Developmental disorders of speech and language were identified in 555,774 AOK-insurants (61.2% males and 38.8% females). Treatment data indicate a substantial proportion newly diagnosed stuttering individuals receive treatment (up to 45% of 6-year-old patients), with slightly fewer than 20 sessions per year, on average. We confirmed a previous study showing increased rates of atopic disorders and neurological and psychiatric comorbidities in individuals with stuttering, cluttering, and developmental disorders of speech and language. CONCLUSION: This is the first nationwide study using health insurance data to analyze the prevalence and newly diagnosed cases of a speech and language disorder. Prevalence and gender ratio data were consistent with the international literature. The crude prevalence of developmental disorders of speech and language increased from 2015 to 2018, whereas the crude prevalence for stuttering remained stable. For cluttering, the numbers were too low to draw reliable conclusions. Proportional treatment allocation for stuttering peaked at 6 years of age, which is the school entrance year, and is later than the prevalence peak of stuttering. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8071871/ /pubmed/33912020 http://dx.doi.org/10.3389/fnhum.2021.645292 Text en Copyright © 2021 Sommer, Waltersbacher, Schlotmann, Schröder and Strzelczyk. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Sommer, Martin Waltersbacher, Andrea Schlotmann, Andreas Schröder, Helmut Strzelczyk, Adam Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data |
title | Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data |
title_full | Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data |
title_fullStr | Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data |
title_full_unstemmed | Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data |
title_short | Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data |
title_sort | prevalence and therapy rates for stuttering, cluttering, and developmental disorders of speech and language: evaluation of german health insurance data |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071871/ https://www.ncbi.nlm.nih.gov/pubmed/33912020 http://dx.doi.org/10.3389/fnhum.2021.645292 |
work_keys_str_mv | AT sommermartin prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata AT waltersbacherandrea prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata AT schlotmannandreas prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata AT schroderhelmut prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata AT strzelczykadam prevalenceandtherapyratesforstutteringclutteringanddevelopmentaldisordersofspeechandlanguageevaluationofgermanhealthinsurancedata |